Body Mass Index (BMI) has been a longstanding tool in clinical practice for categorizing patients as “underweight,” “overweight,” or “obese.”…
Browsing: Clinical Updates
VANCOUVER—The incidence, prevalence and mortality associated with colorectal cancer all declined in the United States from 1990 to 2019, but…
In this month’s column, I highlight three topics that are highly relevant to endoscopy clinical practice: colon polyp sizing, Helicobacter…
Mainz Biomed N.V., a molecular genetics diagnostic company specializing in early cancer detection, has unveiled the significant findings of its…
Skyrizi (Risankizumab) demonstrated its non-inferiority to Stelara in achieving clinical remission at 24 weeks and its superiority in endoscopic remission…
Olympus Corporation, a leading global medical technology company, has announced the market launch of its next-generation EVIS X1™ endoscopy system.…
CHICAGO—On average, surgeons are much less likely than gastroenterologists to detect adenomas during routine screening colonoscopy, according to a VA…
The Association for Molecular Pathology (AMP), in collaboration with the American Society of Clinical Oncology (ASCO) and the College of…
Medical-device company Invenio Imaging is at the forefront of a technological breakthrough. They are developing a system that allows surgeons…
Dr. Aasma Shaukat, a gastroenterologist and researcher in colon cancer screening, discusses the conflicting colorectal cancer (CRC) screening recommendations. The…